Publications

PrEP Product Awareness, Preferences, and Past Experiences among Transgender Women and Men Who Have Sex with Men in Asia and Australia (PrEP APPEAL) was a survey study in 16 countries and territories in Asia and Australia. The overall goal of PrEP APPEAL was to identify values and preferences about PrEP, as well as barriers and facilitators to PrEP uptake, among men who have sex with men (MSM) and transgender women (TGW) in Asia and Australia. Key findings

• PrEP awareness was high with 81% of TGW, 80% of MSM in Asian low- and middle-income countries, 91% of MSM in high-income countries and 97% of MSM in Australia having heard of PrEP.
• Among participants who had heard of PrEP, 48% of TGW, 25% of MSM in Asian low- and middle-income countries, 19% of MSM in Asian high-income countries, and 47% of MSM in Australia were current PrEP users.
• Of those who had never taken PrEP, 57% of TGW, 72% of MSM in Asian low- and middle-income countries, 70% of MSM in Asian high-income countries, and 65% of MSM in Australia stated that they would like to take PrEP.
• Across all populations, cost was the most important driver of choice to use PrEP.
• The type of PrEP was the next most important driver of choice to use PrEP for TGW, MSM in Asian low- and middle-income countries, and MSM in Australia.
• Side effects were the second most important driver of choice to use PrEP for MSM in Asian high-income countries.

Drug use continues to be high worldwide. In 2021, 1 in every 17 people aged 15–64 in the world had used a drug in the past 12 months. The estimated number of users grew from 240 million in 2011 to 296 million in 2021 (5.8 per cent of the global population aged 15–64). This is a 23 per cent increase, partly due to population growth. Cannabis continues to be the most used drug, with an estimated 219 million users (4.3 per cent of the global adult population) in 2021. Use of the drug is increasing and although globally cannabis users are mostly men (about 70 per cent), the gender divide is reducing in some subregions; women account for 42 per cent of cannabis users in North America. It is estimated that in 2021, 36 million people had used amphetamines, 22 million had used cocaine and 20 million had used “ecstasy”-type substances in the past year. The proportion of female users is higher in the case of amphetamine-type stimulants (45 per cent of users are women) and non-medical use of pharmaceuticals (between 45 and 49 per cent of users are women), whereas the highest share of men is found in users of opiates (75 per cent) and cocaine (73 per cent). Opioids continue to be the group of substances with the highest contribution to severe drug-related harm, including fatal overdoses. An estimated 60 million people engaged in non-medical opioid use in 2021, 31.5 million of whom used opiates (mainly heroin).

Two decades ago, the global AIDS pandemic seemed unstoppable. More than 2.5 million people were acquiring HIV each year, and AIDS was claiming 2 million lives a year.  UNAIDS data show that today, 29.8 million of the 39 million [33.1 million–45.7 million] people living with HIV globally are receiving life-saving treatment. An additional 1.6 million people received HIV treatment in each of 2020, 2021 and 2022. The path to ending AIDS is clear. We have a solution if we follow the leadership of countries that have forged strong political commitment to put people first and invest in evidence-based HIV prevention and treatment programmes.

Insights from Indonesia, Thailand, and the Philippines, is a situational analysis developed by Youth LEAD to explore the healthcare inclusion of transgender youth in the Asia- Pacific, particularly in Indonesia, Thailand, and the Philippines. This study was conducted as a formative research in understanding the challenges and opportunities on good practices of transgender health for youth and proposing culturally-appropriate recommendations. This study was conducted under the partnership umbrella between Youth LEAD and Asia Pacific Transgender Network (APTN), under the Project “Transcending Borders: Strengthening trans and gender diverse movements towards transformative leadership, legal protection and trans-competent healthcare in Asia-Pacific and Africa” funded by the Robert Carr Fund (RCF).

The “Engagement of Youth in the Country Coordinating Mechanism and Global Fund Processes in the Asia-Pacific” situation analysis is an advocacy tool for young key populations across the Asia-Pacific region. This is the product of Youth LEAD, the Asia-Pacific Network of young key populations, developed with the technical assistance of Frontline AIDS; a partnership of organizations working with communities in more than 100 countries, taking local, national and global action on HIV, health and human rights and financially supported by the Global Fund Community Engagement Strategic Initiative. All rights reserved. Publication of the Youth LEAD can be obtained from the Youth LEAD website (youth-lead.org) and official address below. Requests for the permission to reproduce or translate Youth LEAD publications- for noncommercial distribution only- should be addressed to the Youth LEAD Secretariat.

The “Young Key Population and Youths Engagement in the Global Fund 7th Grant Cycle” is an engagement tool for youth-led organizations and Country Coordinating Mechanisms (CCM) across Asia-Pacific countries in supporting their process of submitting Global Fund funding requests.

About this Evaluation UNAIDS Independent Evaluation Office requested an evaluation of the regional Data Hubs in order to understand and explore: History of the creation and implementation of the regional Data Hubs. The existing programmatic and technical design and implementation of the Data Hubs. The implicit theory of change, i.e., how the Data Hubs are intended to support and link to UNAIDS larger Mission and Global Strategy. Recommendations for the future of the Data Hubs.

UNAIDS DATA 2022

Overview: The 2023-2025 allocation methodology drives funding to higher burden, lower income countries, specifically accounting for HIV epidemics among key and vulnerable populations, the threat of multidrug-resistant tuberculosis (TB) and the risk of malaria resurgence. Where there is a decrease in funding, the methodology provides sustainable and paced reductions.

The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions into their ongoing monitoring efforts and to report comprehensive national data through the Global AIDS Monitoring (GAM) process. In this way they will contribute to improving understanding of the global response to the HIV epidemic, including progress that has been made towards achieving the commitments and global targets set out in the new United Nations Political Declaration on HIV and AIDS: Ending Inequalities and Getting on Track to End AIDS by 2030, adopted in June 2021, and the linked Sustainable Development Goals.